- This event has passed.
Task force deep dive: GBA Taskforce
June 17, 2021 @ 9:30 am - 11:30 am
Free
The Hong Kong SAR government announced in November 2019 that Hong Kong registered drugs could be used by Hong Kong-owned medical institutions in GBA. We have supported HKU-SZ hospital for the pilot of the policy since then, and GBA Taskforce members have been working hard to work on the details and implementation of the policy throughout the journey.
Recently, HKAPI members have at least a drug able to go through the process and procedure. Therefore, the GBA Task Force is organizing an online deep-dive session, so that subject-matter experts would share the latest updates and experience of the HKU-SZ Hospital pilot program, as well as the potential opportunities and action plan for 2021. The GBA task force is also excited to solicit input and thoughts from functional specialists in our member companies.
Date: 17 June 2021 (Thursday)
Time: 9:30am to 11:30am (2 hours)
Format: Webinar
Fee: HKD 450
Language: Cantonese and Mandarin
Target Audience: General Managers and Functional Managers (Members only)
If you have any questions or particular area would like to address about GBA policies and HKU-SZ Hospital pilot program, please feel free to write to, or contact Ms Louisa Yuen (louisa.yuen@hkapi.hk) in advance.
| Time | Topic | Speakers |
| 9:30 – 9:35 | Opening | Mr Richard Sun,
Sponsor of the GBA taskforce |
| 9:35 – 9:45 | Evolution of the GBA Policies on HK-registered drugs to be used in GBA | Ms Sabrina Chan and
Ms Phoebe Mo, member of the GBA taskforce |
| 9:45 – 10:15 | Introduction of HKU-SZH Pilot Program, incl. drug listing submission and review process; drug listing criteria | Mr Harry Fung and Mr Kenny Lam, members of the GBA taskforce |
| 10:15 – 10:30 | Q&A Session | All |
| 10:30 – 10:35 | Break | |
| 10:35 – 11:05 | Importation logistics and business model options | Mr Lewis Huen, Mr Danny Ko, Ms Emily Lau, Ms Tammie Ng, Mr Hugo Tan and Ms Ingrid Wong, members of the GBA taskforce |
| 11:05 – 11:10 | Cross-border drug education?_ Compliance perspective | Representative from the Ethics & Compliance taskforce |
| 11:10 – 11:20 | Q&A Session | All |
| 11:20 – 11:30 | Challenges and Opportunities | Ms Dora Mo, Lead of the GBA taskforce and Mr Kenny Lee, Mr Stephen Lee, members of the GBA taskforce |
